Cagrilintide 5mg+Semaglutide 5mg
For Research Use Only · Not for Human Consumption
Weight lossMetabolicResearch stack
Research blend combining 5 mg of cagrilintide and 5 mg of semaglutide in a single vial. Used in combined amylin/GLP-1 receptor-pharmacology research. Supplied as lyophilized powder at ≥98% HPLC purity. For Research Use Only. Not for Human Consumption. Not a drug, food, or cosmetic.
Potential benefits — preclinical research
- •CagriSema dual mechanism — amylin + GLP-1 — drove 13.7% weight loss in NEJM trials.
- •73.5% of trial participants reached HbA1c ≤ 6.5%.
- •Preserved lean mass relative to single-agonist comparators in early studies.
Findings reported in published in-vitro / animal studies. Not therapeutic claims — for research use only.
Certificate of Analysis
View certificateOut of stock
—per vial